Literature DB >> 2401399

Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus.

D J Pettitt1, M F Saad, P H Bennett, R G Nelson, W C Knowler.   

Abstract

We studied the occurrence of renal disease by measuring serum creatinine and urine protein concentrations in the diabetic members of 316 Pima Indian families with Type 2 (non-insulin-dependent) diabetes in two successive generations to determine if diabetic renal disease aggregates in families. After adjustment for sex and other risk factors, proteinuria occurred among 14.3% of the diabetic offspring if neither parent had proteinuria, 22.9% if at least one diabetic parent had proteinuria, and 45.9% if both parents had diabetes and proteinuria. Among male offspring, an elevated serum creatinine concentration (greater than or equal to 177 mumol/l) was present in 11.7% if the parent had an elevated creatinine and in 1.5% if the parent did not. Thus, proteinuria and high serum creatinine aggregated in diabetic families, suggesting that susceptibility to renal disease is inherited independently of diabetes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401399     DOI: 10.1007/bf00404096

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

Authors:  A S Krolewski; M Canessa; J H Warram; L M Laffel; A R Christlieb; W C Knowler; L I Rand
Journal:  N Engl J Med       Date:  1988-01-21       Impact factor: 91.245

2.  Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians.

Authors:  C L Kunzelman; W C Knowler; D J Pettitt; P H Bennett
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

3.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

4.  Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: evidence for an immunogenetic predisposition.

Authors:  C Mijovic; J A Fletcher; A R Bradwell; A H Barnett
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-15

5.  A clinical and histologic study of diabetic nephropathy in the Pima Indians.

Authors:  S A Kamenetzky; P H Bennett; S E Dippe; M Miller; P M LeCompte
Journal:  Diabetes       Date:  1974-01       Impact factor: 9.461

6.  Use of single voided urine samples to estimate quantitative proteinuria.

Authors:  J M Ginsberg; B S Chang; R A Matarese; S Garella
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

7.  Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion.

Authors:  H H Parving; B Oxenbøll; P A Svendsen; J S Christiansen; A R Andersen
Journal:  Acta Endocrinol (Copenh)       Date:  1982-08

8.  Early onset of clinical diabetic nephropathy in children--a new subgroup?

Authors:  M C Chobanian; R L Chevalier; B C Sturgill; W K Bolton
Journal:  Int J Pediatr Nephrol       Date:  1984-03

9.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

10.  Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study.

Authors:  A R Andersen; J S Christiansen; J K Andersen; S Kreiner; T Deckert
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

View more
  71 in total

Review 1.  Role of ACE inhibitors in patients with diabetes mellitus.

Authors:  D J Cordonnier; P Zaoui; S Halimi
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease.

Authors:  Hong Chen; Ming Yu; Ming Li; Ruie Zhao; Qihan Zhu; Wenrui Zhou; Ming Lu; Yufeng Lu; Taishan Zheng; Jiamei Jiang; Weijing Zhao; Kunsan Xiang; Weiping Jia; Limei Liu
Journal:  Mol Cell Biochem       Date:  2011-12-14       Impact factor: 3.396

3.  Factors associated with diabetic nephropathy in subjects with proliferative retinopathy.

Authors:  Caroline Jane Magri; Neville Calleja; Gerald Buhagiar; Stephen Fava; Josanne Vassallo
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

4.  Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy.

Authors:  G Gruden; P Cavallo-Perin; C Olivetti; E Repetti; R Sivieri; A Bruno; G Pagano
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

Review 5.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 6.  Risk predictors in patients with diabetic nephropathy.

Authors:  P Fioretto; M L Caramori; M Dalla Vestra; M Mauer
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 7.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 8.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 9.  Genetics of diabetes complications.

Authors:  Donald W Bowden
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

10.  Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy.

Authors:  P K Chandie Shaw; L A van Es; L C Paul; F R Rosendaal; J H M Souverijn; J P Vandenbroucke
Journal:  Diabetologia       Date:  2003-05-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.